Table 2.
β | p-value | |
---|---|---|
TXNIP cg19693031 (ref: ≥ Q3) | ||
Q2–Q3 | − 0.0236 | 0.965 |
Q1–Q2 | 1.0317 | 0.058 |
< Q1 | 1.3336 | 0.019 |
P for trend | 0.005 | |
GLUT1 rs841853 (ref: CC) | ||
CA + AA | − 0.4576 | 0.232 |
Sex (ref: Women) | ||
Men | 2.4784 | < .001 |
Age | 0.1935 | < .001 |
BMI | 0.1647 | 0.006 |
Cigarette smoking (ref: No) | ||
Yes | 0.7118 | 0.166 |
Alcohol drinking (ref: No) | ||
Yes | 1.2013 | 0.086 |
Triglyceride | 0.0031 | 0.146 |
HDL-C | − 0.0338 | 0.037 |
LDL-C | 0.0094 | 0.112 |
Hypertension (ref: No) | ||
Yes | 0.3245 | 0.540 |
Exercise (ref: No) | ||
Yes | − 0.3790 | 0.362 |
Tea intake (ref: No) | ||
Yes | 0.1308 | 0.742 |
Coffee intake (ref: No) | ||
Yes | − 0.2297 | 0.564 |
Vegetarian diet (ref: No) | ||
Yes | − 1.9887 | 0.004 |
TXNIP cg19693031*SLC2A1 rs841853 | p-value = 0.036 |
TXNIP thioredoxin-interacting protein, GLUT1 glucose transporter 1, β beta coefficient, ref reference, BMI body mass index, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, *: interaction term